Chimpanzees formerly used in hepatitis B vaccine experiments in laboratories are receiving health checks after being moved to a new home in Liberia. The checks are part of long-term care intended to support the animals’ recovery and ongoing wellbeing.
The reports, which draw from an AP dispatch, describe the transfer and indicate that the assessments are meant to give the chimpanzees a “second chance” at a more normal life. Across outlets, the central focus is the shift from research use to sanctuary-style aftercare, beginning with veterinary evaluation.
While most coverage is brief and does not provide extensive detail beyond the move and the health screening, all sources align on the key elements: the chimpanzees’ prior role in hepatitis B vaccine experiments, their relocation to Liberia, and the provision of medical check-ups as the first step in a longer care plan.
